| 785 |
morphological change |
retina layer formation
(GO:0010842)
|
retina
(UBERON:0000966)
|
1877: Altered, retinal layer structure
|
| 784 |
increased |
vascular inflammation
(MP:0001863)
|
|
1867: Bradykinin system, hyperactivated
|
| 783 |
increased |
vasodilation
(GO:0042311)
|
|
1867: Bradykinin system, hyperactivated
|
| 782 |
increased |
increased vascular permeability
(MP:0003070)
|
|
1867: Bradykinin system, hyperactivated
|
| 781 |
decreased |
negative regulation of blood coagulation
(GO:0030195)
|
|
1866: Fibrinolysis, decreased
|
| 780 |
increased |
negative regulation of fibrinolysis
(GO:0051918)
|
|
1866: Fibrinolysis, decreased
|
| 779 |
decreased |
microphthalmia
(MP:0001297)
|
eye
(UBERON:0000970)
|
1878: Decreased, Eye size
|
| 778 |
decreased |
protein tyrosine kinase activity
(GO:0004713)
|
tyrosine-protein kinase fyna (zebrafish)
(PR:Q6EWH2)
|
1884: Inhibition of Fyna
|
| 777 |
decreased |
mRNA transcription
(GO:0009299)
|
aromatase
(PR:000006100)
|
408: reduction in ovarian granulosa cells, Aromatase (Cyp19a1)
|
| 776 |
decreased |
protein secretion
(GO:0009306)
|
vitellogenins
(MESH:D014819)
|
285: Reduction, Vitellogenin synthesis in liver
|
| 775 |
decreased |
protein secretion
(GO:0009306)
|
|
None
|
| 774 |
increased |
|
deoxyribonucleic acid
(CHEBI:16991)
|
1879: Bulky DNA adducts, increase
|
| 773 |
occurrence |
regulation of cellular response to drug
(GO:2001038)
|
|
1651: Treatment-resistant gastric cancer
|
| 772 |
occurrence |
epithelial to mesenchymal transition
(GO:0001837)
|
cellular_component
(GO:0005575)
|
None
|
| 771 |
occurrence |
regulation of beta-catenin-TCF complex assembly
(GO:1904863)
|
beta-catenin-TCF complex
(GO:1990907)
|
1755: beta-catenin activation
|
| 770 |
disrupted |
mRNA transcription
(GO:0009299)
|
angiotensin-converting enzyme 2
(PR:000003622)
|
None
|
| 769 |
increased |
neuropilin binding
(GO:0038191)
|
|
None
|
| 768 |
increased |
protease binding
(GO:0002020)
|
|
None
|
| 767 |
increased |
endocytosis involved in viral entry into host cell
(GO:0075509)
|
|
None
|
| 766 |
occurrence |
regulation of response to reactive oxygen species
(GO:1901031)
|
reactive oxygen species
(CHEBI:26523)
|
1634: Increase, Oxidative DNA damage
|
| 765 |
increased |
response to reactive oxygen species
(GO:0000302)
|
reactive oxygen species
(CHEBI:26523)
|
2 Events
|
| 764 |
increased |
cellular response to oxidative stress
(GO:0034599)
|
reactive oxygen species
(CHEBI:26523)
|
1869: Diminished protective oxidative stress response
|
| 763 |
increased |
viral translation
(GO:0019081)
|
ssRNA viral genome
(GO:0019024)
|
1847: Increased SARS-CoV-2 production
|
| 762 |
increased |
mRNA transcription
(GO:0009299)
|
ssRNA viral genome
(GO:0019024)
|
1847: Increased SARS-CoV-2 production
|
| 761 |
increased |
viral RNA genome packaging
(GO:0019074)
|
viral assembly compartment
(GO:0072516)
|
1847: Increased SARS-CoV-2 production
|